# Resilient Pharmaceuticals clinical trials: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials with Resilient Pharmaceuticals as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Resilient Pharmaceuticals: 30 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/resilient-pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 13, 2026 | NCT07584720 | Study of Midomafetamine in Healthy Adults | Resilient Pharmaceuticals | Phase 1 | Active not recruiting | Healthy Volunteers | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07584720) |
| December 30, 2021 | NCT05173831 | Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans | Resilient Pharmaceuticals | Phase 2 | Withdrawn | PTSD | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05173831) |
| December 7, 2021 | NCT05147402 | Food Effects on Bioavailability of MDMA in Healthy Volunteers | Resilient Pharmaceuticals | Phase 1 | Completed | Pharmacokinetics | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05147402) |
| October 4, 2021 | NCT05066282 | Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD | Resilient Pharmaceuticals | Observational | Completed | PTSD | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05066282) |
| July 20, 2021 | NCT04968938 | Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD | Resilient Pharmaceuticals | Phase 2 | Withdrawn | Posttraumatic Stress Disorder | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04968938) |
| March 5, 2021 | NCT04784143 | Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD | Resilient Pharmaceuticals | Phase 2 | Terminated | PTSD | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04784143) |
| January 19, 2021 | NCT04714359 | A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD | Resilient Pharmaceuticals | Phase 3 | Completed | PTSD | 87 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04714359) |
| July 1, 2020 | NCT04454684 | A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders | Resilient Pharmaceuticals | Phase 2 | Withdrawn | Anorexia Nervosa Restricting Type, Binge-Eating Disorder | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04454684) |
| June 18, 2020 | NCT04438512 | A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD | Resilient Pharmaceuticals | Not applicable | No longer available | Post Traumatic Stress Disorder | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04438512) |
| September 4, 2019 | NCT04077437 | A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2) | Resilient Pharmaceuticals | Phase 3 | Completed | Posttraumatic Stress Disorder | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04077437) |
| August 29, 2019 | NCT04073433 | Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2) | Resilient Pharmaceuticals | Phase 1 | Withdrawn | Psychological Effects of Study Drug | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04073433) |
| July 31, 2018 | NCT03606538 | MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function | Resilient Pharmaceuticals | Phase 1 | Not yet recruiting | Pharmacokinetics, Hepatic Impairment | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03606538) |
| May 25, 2018 | NCT03537014 | A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) | Resilient Pharmaceuticals | Phase 3 | Completed | Posttraumatic Stress Disorder | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03537014) |
| April 2, 2018 | NCT03485287 | Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) | Resilient Pharmaceuticals | Phase 2 | Completed | Posttraumatic Stress Disorder | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03485287) |
| September 13, 2017 | NCT03282123 | Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD | Resilient Pharmaceuticals | Phase 2 | Completed | PTSD | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03282123) |
| June 9, 2017 | NCT03181763 | Evaluation of MDMA on Startle Response | Resilient Pharmaceuticals | Phase 1 | Completed | Startle Response | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03181763) |
| November 3, 2016 | NCT02954562 | Correlates of Anxiety Associated With a Life-threatening Illness | Resilient Pharmaceuticals | Observational | Completed | Anxiety | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02954562) |
| August 23, 2016 | NCT02876172 | MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD | Resilient Pharmaceuticals | Phase 1/2 | Completed | Posttraumatic Stress Disorder | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02876172) |
| April 28, 2015 | NCT02427568 | MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness | Resilient Pharmaceuticals | Phase 2 | Completed | Anxiety | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02427568) |
| April 3, 2014 | NCT02102802 | Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD | Resilient Pharmaceuticals | Observational | Completed | Posttraumatic Stress Disorder | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02102802) |
| December 11, 2013 | NCT02008396 | Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults | Resilient Pharmaceuticals | Phase 2 | Completed | Social Anxiety in Autistic Adults | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02008396) |
| October 9, 2013 | NCT01958593 | Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD | Resilient Pharmaceuticals | Phase 2 | Terminated | Posttraumatic Stress Disorder | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01958593) |
| February 15, 2013 | NCT01793610 | Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD | Resilient Pharmaceuticals | Phase 2 | Completed | Posttraumatic Stress Disorder | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01793610) |
| September 21, 2012 | NCT01689740 | Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD | Resilient Pharmaceuticals | Phase 2 | Completed | Posttraumatic Stress Disorder (PTSD) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01689740) |
| October 24, 2011 | NCT01458327 | Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial | Resilient Pharmaceuticals | Phase 2 | Completed | Posttraumatic Stress Disorder | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01458327) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 1/2 | 1 |
| Phase 2 | 16 |
| Phase 3 | 3 |
| Not applicable | 1 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Withdrawn | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| No longer available | 1 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Stress Disorders, Post-Traumatic | 20 |
| Anxiety Disorders | 2 |
| Autistic Disorder | 1 |
| Depression | 1 |
| Binge-Eating Disorder | 1 |
| Emotional Regulation | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Private jet charter companies in the United States](https://specstream.ai/data/businesses/private-jet-charter-companies/united-states)
- [Medical transportation companies in the United States](https://specstream.ai/data/businesses/medical-transportation-companies/united-states)
- [Hong Kong style cafes in the United States](https://specstream.ai/data/businesses/hong-kong-style-cafes/united-states)
- [Empanada restaurants in the United States](https://specstream.ai/data/businesses/empanada-restaurants/united-states)
- [Caterers in the United States](https://specstream.ai/data/businesses/caterers/united-states)
